ABL Bio has ranked among the top searched stocks for 13 days in the past month.

As of 12:30 PM on the 25th, ABL Bio is trading at 33,850 KRW, up 2.27% from the previous day. This marks an 85.99% increase compared to May 28. ABL Bio is known as a specialized company developing biopharmaceuticals based on antibody therapeutics.

Today, foreigners have a net purchase of 26,000 shares of ABL Bio, and institutions have a net purchase of 1,000 shares, according to provisional data. Over the past five days, individual investors have net purchased 88,396 shares, while foreigners and institutions have net purchased 106,846 shares and net sold 81,529 shares, respectively.

On June 16, ABL Bio was a market topic with the headline "Benefiting from SK Biopharm's IPO... Discussing technology transfers with 15 big pharma companies."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing